JP2020533308A5 - - Google Patents

Download PDF

Info

Publication number
JP2020533308A5
JP2020533308A5 JP2020513753A JP2020513753A JP2020533308A5 JP 2020533308 A5 JP2020533308 A5 JP 2020533308A5 JP 2020513753 A JP2020513753 A JP 2020513753A JP 2020513753 A JP2020513753 A JP 2020513753A JP 2020533308 A5 JP2020533308 A5 JP 2020533308A5
Authority
JP
Japan
Prior art keywords
formula
composition
compound
substituted
needed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2020513753A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020533308A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/050095 external-priority patent/WO2019051322A1/en
Publication of JP2020533308A publication Critical patent/JP2020533308A/ja
Publication of JP2020533308A5 publication Critical patent/JP2020533308A5/ja
Priority to JP2023022825A priority Critical patent/JP2023053386A/ja
Ceased legal-status Critical Current

Links

JP2020513753A 2017-09-08 2018-09-07 チューブリシンおよびそれらの中間体の調製のためのプロセス Ceased JP2020533308A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023022825A JP2023053386A (ja) 2017-09-08 2023-02-16 チューブリシンおよびそれらの中間体の調製のためのプロセス

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762556234P 2017-09-08 2017-09-08
US62/556,234 2017-09-08
PCT/US2018/050095 WO2019051322A1 (en) 2017-09-08 2018-09-07 PROCESS FOR THE PREPARATION OF TUBULYSINS AND INTERMEDIATES THEREOF

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023022825A Division JP2023053386A (ja) 2017-09-08 2023-02-16 チューブリシンおよびそれらの中間体の調製のためのプロセス

Publications (2)

Publication Number Publication Date
JP2020533308A JP2020533308A (ja) 2020-11-19
JP2020533308A5 true JP2020533308A5 (https=) 2021-10-14

Family

ID=63963374

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020513753A Ceased JP2020533308A (ja) 2017-09-08 2018-09-07 チューブリシンおよびそれらの中間体の調製のためのプロセス
JP2023022825A Pending JP2023053386A (ja) 2017-09-08 2023-02-16 チューブリシンおよびそれらの中間体の調製のためのプロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023022825A Pending JP2023053386A (ja) 2017-09-08 2023-02-16 チューブリシンおよびそれらの中間体の調製のためのプロセス

Country Status (15)

Country Link
US (2) US11389543B2 (https=)
EP (1) EP3679036A1 (https=)
JP (2) JP2020533308A (https=)
KR (1) KR20200051733A (https=)
CN (1) CN111601803A (https=)
AU (1) AU2018329951B2 (https=)
BR (1) BR112020004495A2 (https=)
CA (1) CA3073766A1 (https=)
EA (1) EA202090670A1 (https=)
IL (1) IL272837B2 (https=)
MA (1) MA50124A (https=)
MX (1) MX2020001928A (https=)
SG (1) SG11202001543XA (https=)
TW (2) TWI820038B (https=)
WO (1) WO2019051322A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20200051733A (ko) * 2017-09-08 2020-05-13 시애틀 지네틱스, 인크. 튜불리신 및 그 중간물의 제조 공정
US20230002440A1 (en) * 2018-09-07 2023-01-05 Seattle Genetics, Inc. Alternative processes for the preparation of tubulysins and intermediates thereof
BR112023018676A2 (pt) 2021-03-18 2023-10-10 Seagen Inc Conjugado anticorpo-fármaco, composição farmacêutica, métodos de tratamento de uma doença ou condição e de um câncer, e, composição de conjugado ligante-fármaco

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10230872A1 (de) * 2002-07-09 2004-01-22 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Verfahren zur Herstellung von substituierten Thiazol-2-ylmethylestern
ES2708763T3 (es) 2005-07-07 2019-04-11 Seattle Genetics Inc Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
EP2032606B1 (en) 2006-05-30 2013-11-27 Genentech, Inc. Antibodies and immunoconjugates and uses therefor
ES2649941T3 (es) 2007-02-23 2018-01-16 Aileron Therapeutics, Inc. Aminoácidos sustituidos para preparar péptidos macrocíclicos unidos a triazol
US20100047841A1 (en) * 2007-02-27 2010-02-25 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Synthesis of desacetoxytubulysin h and analogs thereof
AU2013229786B2 (en) 2012-03-08 2017-06-22 Halozyme, Inc. Conditionally active anti-epidermal growth factor receptor antibodies and methods of use thereof
CN104640572B (zh) 2012-05-15 2018-04-27 索伦托医疗有限公司 药物偶联物,偶联方法,及其用途
WO2013173337A2 (en) 2012-05-15 2013-11-21 Seattle Genetics, Inc. Self-stabilizing linker conjugates
EP2708243A1 (en) * 2012-09-17 2014-03-19 OntoChem GmbH Receptor ligand linked cytotoxic molecules
MX369022B (es) 2013-05-31 2019-10-25 Genentech Inc Anticuerpos anti-ácido teicoico de la pared celular y conjugados.
RU2687044C2 (ru) 2013-05-31 2019-05-06 Дженентек, Инк. Антитела против стеночной тейхоевой кислоты и их конъюгаты
FI3900742T3 (fi) * 2014-09-11 2024-08-16 Seagen Inc Tertiääristä amiinia sisältävien lääkeaineiden kohdennettu antaminen
AU2015358532C1 (en) * 2014-12-03 2020-10-29 Genentech, Inc. Quaternary amine compounds and antibody-drug conjugates thereof
US10808007B2 (en) * 2015-02-25 2020-10-20 William Marsh Rice University Desacetoxytubulysin H and analogs thereof
KR20200051733A (ko) * 2017-09-08 2020-05-13 시애틀 지네틱스, 인크. 튜불리신 및 그 중간물의 제조 공정

Similar Documents

Publication Publication Date Title
JP6356876B2 (ja) 抗ウイルス化合物の合成
ES2842123T3 (es) Purificación de tenofovir alafenamida y sus intermedios
SG11202112875UA (en) Compounds for treatment of pd-l1 diseases
US9676803B2 (en) Efficient process for separation of diastereomers of 9-[(R)-2-[[(R,S)-[[(S)-1-(isopropoxycarbonyl)ethyl]amino]-phenoxyphosphinyl]methoxy]propyl]adenine
JP2014509322A5 (https=)
JP2020533308A5 (https=)
JP2018504437A5 (https=)
JP2020534336A5 (https=)
EP3658549A1 (en) Process for preparing and purifying the lfa-1 antagonist lifitegrast
CN107735398A (zh) 用于合成雷帕霉素衍生物的方法
AU2018371771A1 (en) Solid state form of Valbenazine
US10584100B2 (en) Solid state forms of netarsudil mesylate
JP2024530795A (ja) ニロガセスタットの合成
EP3091007A1 (en) Process for the preparation of piperidine compounds
JP6851149B2 (ja) ピペリジン化合物の製造方法
IL272837B1 (en) A process for preparing tubolysins and their intermediates
WO2017118928A1 (en) Process for the separation of diastereomers of tenofovir alafenamide
JP2021536475A5 (https=)
JPWO2021015109A5 (https=)
JP2013520440A5 (https=)
JP2024525792A5 (https=)
JP2024516199A (ja) バルベナジンの合成方法
US11905250B2 (en) Methods for preparation of jasmonate compounds
WO2020206367A1 (en) Processes for the preparation of deuterated d-serine
JPH02290889A (ja) 不飽和アミノカルボン酸誘導体